View in EDS

Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.

Saved in:
Bibliographic Details
Title: Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.
Authors: Fan W; Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Li Y; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China., Shi H; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China., Guo J; Department of Urology, Fudan University Zhongshan Hospital, Shanghai, China., Huang R; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China., Dong Q; Department of Urology, West China Hospital, Sichuan University, Chengdu, China., Yang Z; Department of Nuclear Medicine, Peking University Cancer Hospital, Beijing, China., Yang Y; Department of Urology, Peking University Cancer Hospital, Beijing, China., Wang X; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Gu D; Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China., Wang F; Department of Nuclear Medicine, Nanjing First Hospital, Nanjing, China., Wang J; Department of Nuclear Medicine, Xijing Hospital, Xi'an, China., Xu D; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Jiang Z; Novartis Biomedical Research, Shanghai, China., Li H; Novartis Development, Beijing, China., Li J; Novartis Development, Shanghai, China., Li R; Novartis Pharmaceuticals Corporation, Shanghai, China., Huo L; Peking Union Medical College Hospital, Beijing, China., Ji Z; Peking Union Medical College Hospital, Beijing, China.
Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2026 Jun; Vol. 41 (5), pp. 430-438. Date of Electronic Publication: 2026 Feb 14.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41689461
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics and Dosimetry of [<superscript>68</superscript>Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fan+W%22">Fan W</searchLink>; Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Shi+H%22">Shi H</searchLink>; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Guo+J%22">Guo J</searchLink>; Department of Urology, Fudan University Zhongshan Hospital, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Huang+R%22">Huang R</searchLink>; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Dong+Q%22">Dong Q</searchLink>; Department of Urology, West China Hospital, Sichuan University, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Yang+Z%22">Yang Z</searchLink>; Department of Nuclear Medicine, Peking University Cancer Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Department of Urology, Peking University Cancer Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Gu+D%22">Gu D</searchLink>; Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Ye+D%22">Ye D</searchLink>; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Department of Nuclear Medicine, Nanjing First Hospital, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Nuclear Medicine, Xijing Hospital, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Xu+D%22">Xu D</searchLink>; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Z%22">Jiang Z</searchLink>; Novartis Biomedical Research, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Novartis Development, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Novartis Development, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Novartis Pharmaceuticals Corporation, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Huo+L%22">Huo L</searchLink>; Peking Union Medical College Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Ji+Z%22">Ji Z</searchLink>; Peking Union Medical College Hospital, Beijing, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229605408%22">Cancer biotherapy & radiopharmaceuticals</searchLink> [Cancer Biother Radiopharm] 2026 Jun; Vol. 41 (5), pp. 430-438. <i>Date of Electronic Publication: </i>2026 Feb 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%2C+Inc%22">Mary Ann Liebert, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9605408 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-8852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210849785%22">10849785 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Biother Radiopharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41689461
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/10849785251415122
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 430
    Titles:
      – TitleFull: Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fan W
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Shi H
      – PersonEntity:
          Name:
            NameFull: Guo J
      – PersonEntity:
          Name:
            NameFull: Huang R
      – PersonEntity:
          Name:
            NameFull: Dong Q
      – PersonEntity:
          Name:
            NameFull: Yang Z
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Gu D
      – PersonEntity:
          Name:
            NameFull: Ye D
      – PersonEntity:
          Name:
            NameFull: Wang F
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Xu D
      – PersonEntity:
          Name:
            NameFull: Jiang Z
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Huo L
      – PersonEntity:
          Name:
            NameFull: Ji Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1557-8852
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancer biotherapy & radiopharmaceuticals
              Type: main
ResultId 1